Hugh E. Laird
Impact in
-
- Neuroscience and Neuropharmacology Research
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
Papers in
-
- Neuroscience and Neuropharmacology Research 23
-
- Metabolism and Genetic Disorders 3
- Co-authors
- Phillip C. JobeRyan J. HuxtableShirley E. LippincottAnthony L. ParolaHenry I. YamamuraLincoln ChinAlbert L. PicchioniDiane Haddock Russell
- Journals
- Life Sciences (5 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)Epilepsia (3 papers)Toxicology and Applied Pharmacology (3 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- United StatesCzechia
In The Last Decade
Hugh E. Laird
44 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 96
- Cellular and Molecular Neuroscience 805
- Psychiatry and Mental health 249
- Nutrition and Dietetics 176
- Cell Biology 173
- Sensory Systems 48
Countries citing papers authored by Hugh E. Laird
This map shows the geographic impact of Hugh E. Laird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh E. Laird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh E. Laird more than expected).
Fields of papers citing papers by Hugh E. Laird
This network shows the impact of papers produced by Hugh E. Laird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh E. Laird. The network helps show where Hugh E. Laird may publish in the future.
Co-authors
The 25 scholars most cited alongside Hugh E. Laird, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 30 | |
| 2 | 1996 | 45 | |
| 3 | 1993 | 79 | |
| 4 | 1991 | 18 | |
| 5 | 1991 | 61 | |
| 6 | 1990 | 3 | |
| 7 | 1990 | 2 | |
| 8 | 1989 | 1 | |
| 9 | 1989 | 12 | |
| 10 | 1989 | 5 | |
| 11 | 1989 | 30 | |
| 12 | 1988 | 59 | |
| 13 | 1987 | 42 | |
| 14 | 1985 | 79 | |
| 15 | 1983 | 35 | |
| 16 | 1982 | 85 | |
| 17 | 1981 | 116 | |
| 18 | 1979 | 2 | |
| 19 | 1976 | 5 | |
| 20 | 5-HYDROXYTRYPTAMINE AS AN INHIBITORY MODULATOR IN AUDIOGENIC SEIZURE | 1974 | 3 |
About Hugh E. Laird
Hugh E. Laird is a scholar working on Cellular and Molecular Neuroscience, Clinical Biochemistry, Psychiatry and Mental health, Pharmacology and Emergency Medicine, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (23 papers), Epilepsy research and treatment (6 papers), Receptor Mechanisms and Signaling (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Aldose Reductase and Taurine (3 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (805 citations), Psychiatry and Mental health (249 citations), Nutrition and Dietetics (176 citations), Cell Biology (173 citations) and Sensory Systems (48 citations). Hugh E. Laird has collaborated with scholars based in United States and Czechia. Frequent co-authors include Phillip C. Jobe, Ryan J. Huxtable, Shirley E. Lippincott, Anthony L. Parola, Henry I. Yamamura, Lincoln Chin, Albert L. Picchioni, Diane Haddock Russell, Charles W. Putnam and Kwang Ho Ko. Their work appears in journals such as Life Sciences, Journal of Pharmacology and Experimental Therapeutics, Epilepsia, Toxicology and Applied Pharmacology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.